Halyard Health Inc (NYSE:HYH) – Broker Update
Below are the most recently updated broker updates which include ratings and price targets for Halyard Health Inc (NYSE:HYH).
08/10/2016 – Broker: Deutsche Bank Rating: buy New Target: 41 reiteration
08/04/2016 – Broker: Stifel Nicolaus Rating: buy New Target: 38 reiteration
12/18/2015 – Broker: KeyBanc Rating: sector weight newcoverage
11/04/2015 – Broker: JMP Securities Rating: market outperform New Target: 40 reiteration
10/12/2015 – Broker: Morgan Stanley Rating: underweight New Target: 27 downgrade
07/21/2015 – Broker: Raymond James Rating: market perform newcoverage
05/08/2015 – Broker: Zacks Rating: sell downgrade
The average price target from the most recent broker reports is 36.50
The stock increased +0.97% (+0.33) during the last days session, reaching 34.36 and roughly 187178 shares were bought or sold by traders. Halyard Health Inc (NYSE:HYH) has increased by +19.26% over 12 months.